Striking In Vivo Phenotype of a Disease-Associated Human SCN5A Mutation Producing Minimal Changes in Vitro
- 30 August 2011
- journal article
- case report
- Published by Ovid Technologies (Wolters Kluwer Health) in Circulation
- Vol. 124 (9), 1001-1011
- https://doi.org/10.1161/circulationaha.110.987248
Abstract
Background— The D1275N SCN5A mutation has been associated with a range of unusual phenotypes, including conduction disease and dilated cardiomyopathy, as well as atrial and ventricular tachyarrhythmias. However, when D1275N is studied in heterologous expression systems, most studies show near-normal sodium channel function. Thus, the relationship of the variant to the clinical phenotypes remains uncertain. Methods and Results— We identified D1275N in a patient with atrial flutter, atrial standstill, conduction disease, and sinus node dysfunction. There was no major difference in biophysical properties between wild-type and D1275N channels expressed in Chinese hamster ovary cells or tsA201 cells in the absence or presence of β1 subunits. To determine D1275N function in vivo, the Scn5a locus was modified to knock out the mouse gene, and the full-length wild-type (H) or D1275N (DN) human SCN5A cDNAs were then inserted at the modified locus by recombinase mediated cassette exchange. Mice carrying the DN allele displayed slow conduction, heart block, atrial fibrillation, ventricular tachycardia, and a dilated cardiomyopathy phenotype, with no significant fibrosis or myocyte disarray on histological examination. The DN allele conferred gene-dose–dependent increases in SCN5A mRNA abundance but reduced sodium channel protein abundance and peak sodium current amplitudes (H/H, 41.0±2.9 pA/pF at −30 mV; DN/H, 19.2±3.1 pA/pF, PP<0.001 versus H/H). Conclusions— Although D1275N produces near-normal currents in multiple heterologous expression experiments, our data establish this variant as a pathological mutation that generates conduction slowing, arrhythmias, and a dilated cardiomyopathy phenotype by reducing cardiac sodium current.This publication has 48 references indexed in Scilit:
- Multiple Loss-of-Function Mechanisms Contribute to SCN5A-Related Familial Sick Sinus SyndromePLOS ONE, 2010
- An international compendium of mutations in the SCN5A-encoded cardiac sodium channel in patients referred for Brugada syndrome genetic testingHeart Rhythm, 2010
- The cardiac sodium channel mutation delQKP 1507-1509 is associated with the expanding phenotypic spectrum of LQT3, conduction disorder, dilated cardiomyopathy, and high incidence of youth sudden deathEP Europace, 2008
- Molecular and Clinical Characterization of a NovelSCN5AMutation Associated With Atrioventricular Block and Dilated CardiomyopathyCirculation: Arrhythmia and Electrophysiology, 2008
- Sodium channel β1 subunit mutations associated with Brugada syndrome and cardiac conduction disease in humansJCI Insight, 2008
- Cardiac Sodium Channel ( SCN5A ) Variants Associated with Atrial FibrillationCirculation, 2008
- Roles and regulation of the cardiac sodium channel Nav1.5: Recent insights from experimental studiesCardiovascular Research, 2007
- Overlap Syndrome of Cardiac Sodium Channel Disease in Mice Carrying the Equivalent Mutation of Human SCN5A -1795insDCirculation, 2006
- Casq2 deletion causes sarcoplasmic reticulum volume increase, premature Ca2+ release, and catecholaminergic polymorphic ventricular tachycardiaJCI Insight, 2006
- Right Ventricular Fibrosis and Conduction Delay in a Patient With Clinical Signs of Brugada SyndromeCirculation, 2005